Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
The best oral abstract competition was one of the scientific highlights of this year`s EuroCMR conference in Vienna. Six outstanding abstracts were chosen by the program committee for presentation with a large variety of topics including basic and clinical CMR. The well-attended session was chaired by Dr. Francisco Alpendurada (London, UK) and Dr. Ingo Eitel (Lübeck, Germany).
The first presentation by Dr. Münch (Berlin, Germany) assessed the value of magnetic resonance spectroscopy for detection of myocardial injury in autoimmune myocarditis. The results showed that CMR spectroscopy is a promising tool for enhanced metabolic profiling in an animal model of autoimmune myocarditis. The following presentations by Dr. Rodriguez Palomares (Barcelona, Spain) and Dr. Barison (Pisa, Italy) evaluated the effect of transmural myocardial infarctions on myocardial recovery and the prognostic value of T1 mapping CMR in non-ischemic dilated cardiomyopathy. Interestingly, transmural infarctions were not able to conclusively predict myocardial recovery following an acute reperfused infarction. According to the authors this may be mainly explained by the presence of edema within the myocardial scar in the setting of acute reperfused myocardial infarction. In non-ischemic dilated cardiomyopathy the extracellular volume (ECV) assessed by T1-mapping was a strong predictor of prognosis. Further, well designed studies are necessary to confirm these promising results. Dr. Captur (London, UK) presented an elegant study about the fractal complexity of the left ventricle. The group was able to construct an atlas of trabeculation in 3000 Subjects from the Multi-Ethnic Study of Atherosclerosis (MESA). The data are clinically important to identify normal racial variations and to define trabeculae in LV noncompaction cardiomyopathy. The award winning abstract by Dr. Fischer (Montreal, Canada) assessed the detection of inducible ischemia with oxygenation-sensitive CMR in an experimental animal model. Oxygenation-sensitive CMR allows the non-invasive assessment of myocardial oxygenation. It capitalizes on the fact that deoxygenated hemoglobin in blood can act as an intrinsic contrast agent, changing proton signals in a fashion that can be imaged to reflect the level of blood oxygenation. The results of the current study by Dr. Fischer underline, that oxygenation-sensitive CMR may become a major diagnostic tool in patients with suspected coronary artery disease but also for primary or secondary microvascular disease. Finally, Dr. Pontone (Milan, Italy) presented convincing data that dipyridamole stress CMR has a strong long-term prognostic value in patients with known or suspected coronary artery disease.Taken together, this excellent and innovate session convincingly demonstrated that CMR can be successfully applied in various clinical and research applications. The presented studies underline that the clinical role of CMR continues to expand and may stimulate promising future applications of CMR.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved